You are here

  • Home
  • Archive
  • Volume 73, Issue 9
  • HCV-associated cryoglobulinemic vasculitis: triple/dual antiviral treatment and/or rituximab? Reply to the comment by Ignatova et al

Article metrics

Article menu
Download PDFPDF
Electronic pages
Correspondence response
HCV-associated cryoglobulinemic vasculitis: triple/dual antiviral treatment and/or rituximab? Reply to the comment by Ignatova et al

 

Online download statistics by month:

Online download statistics by month: June 2014 to March 2024

AbstractFullPdf
Jun 20142091623
Jul 20141402535
Aug 20143282040
Sep 20141212015
Oct 2014701923
Nov 2014561512
Dec 201467158
Jan 2015462211
Feb 2015271110
Mar 201521169
Apr 20152845
May 20153643
Jun 20152404
Jul 20157010
Aug 20153555
Sep 20154542
Oct 20152611
Nov 20153041
Dec 20151855
Jan 20163411
Feb 20161810
Mar 20161302
Apr 20161534
May 20161821
Jun 20162624
Jul 20161324
Aug 20161911
Sep 20162145
Oct 20162424
Nov 20161621
Dec 2016841
Jan 2017944
Feb 20172012
Mar 20171432
Apr 20172511
May 20172301
Jun 20171610
Jul 20173332
Aug 20173322
Sep 20173631
Oct 20175800
Nov 20174400
Dec 20172500
Jan 20182711
Feb 20183032
Mar 20182641
Apr 20183811
May 20184200
Jun 20185900
Jul 20186500
Aug 20186511
Sep 20186800
Oct 20185111
Nov 20184110
Dec 20183121
Jan 20194400
Feb 20191800
Mar 20193031
Apr 20193600
May 20191300
Jun 20194110
Jul 20191510
Aug 20192900
Sep 20193820
Oct 20192111
Nov 201910100
Dec 20191400
Jan 20201911
Feb 20201713
Mar 2020800
Apr 20201200
May 20201821
Jun 20201121
Jul 20201110
Aug 2020400
Sep 20205200
Oct 20201501
Nov 20201200
Dec 20201200
Jan 20211800
Feb 20213210
Mar 20211400
Apr 2021600
May 20211003
Oct 2021700
Nov 20212510
Dec 20211300
Jan 20221711
Feb 20221710
Mar 20221800
Apr 20221910
May 20224200
Jun 20225000
Jul 20221620
Aug 20224200
Sep 20223400
Oct 20224402
Nov 20222912
Dec 20221200
Jan 20231100
Feb 20234600
Mar 20231100
Apr 2023610
May 20231200
Jun 2023700
Jul 2023700
Aug 20232000
Sep 2023200
Oct 20232100
Nov 20232300
Dec 20232620
Jan 2024900
Feb 2024200
Mar 2024800
Total3768289280